Subjects completed generic and diabetes-specific health-related quality-of-life measures (RAND-36 and Diabetes-39) and a symptom assessment measure (DSC-Revised) at baseline and 6 months post insulin initiation. Mean score change was evaluated. Effect size (ES; Cohen's d) and analysis of covariance were used to examine extent and significance of change both within and between treatment groups.
Subject characteristics were mean age 57 years, males 59 % , duration of diabetes 9.6 years, and baseline HbA1c 8.9 % . In the total sample, significant (P < 0.01) improvements (with small ES) were observed in four of eight RAND-36 subscales (ES range: 0.13–0.24), three of five Diabetes-39 subscales (ES range: 0.09–0.34), and five of eight DSC-Revised subscales (ES range: 0.15–0.38). While significance of within-group changes varied by treatment, only one subscale (physical functioning for LM25) showed deterioration. The changes were not significantly different (P > 0.01) between regimens for any subscales.
Our findings suggest that insulin initiation improves selective PRO in patients with poorly controlled T2DM.